AI / data analytics / healthtech / informatics

SLAS Europe 2024
#AI / data analytics / healthtech / informatics #Awards #Drug discovery #Lab automation #Life sciences #Machine learning #SLAS2024

SLAS Europe 2024 in summary  

DDW Multimedia Editor Megan Thomas travelled to SLAS Europe from 27-29 May in Barcelona, Spain. Having attended a range of sessions and spoken to industry attendees and exhibitors, she reflects on the event.   Opening keynote  Professor Luis Serrano presented the opening keynote of the event on engineering of a human lung bacteria… Read More

#Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Lab automation #Machine learning

Webinar: Using AI, ML and lab automation in drug discovery

In this free webinar, hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. It will take place on 11 June from 3:00 PM – 4:00 PM BST. You will hear from Jonathan… Read More

Webinar date:
Sponsored by Benchling
#News

Robot holds up a pill
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Lab automation #Machine learning

Register for this AI, ML and lab automation webinar now

In this free webinar, hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. It will take place on 11 June from 3:00 PM – 4:00 PM BST. You will hear from Jonathan… Read More

Webinar date:
Sponsored by Benchling
#News

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

AI and robotics
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Lab automation #Machine learning

How is AI and lab automation impacting drug discovery?

In this free webinar, hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. It will take place on 11 June from 3:00 PM – 4:00 PM BST. You will hear from Jonathan… Read More

Webinar date:
Sponsored by Benchling
#News

#AI / data analytics / healthtech / informatics #American Chemical Society #Bioinformatics #Drug discovery

CAS BioFinder Discovery Platform offers drug discovery insights

CAS, a division of the American Chemical Society, has launched the CAS BioFinder Discovery Platform, designed to reveal novel drug discovery insights through data connections. The offering provides drug discovery scientists with the ability to explore known and predicted data, find answers to their questions, and… Read More

#News

#AI / data analytics / healthtech / informatics #Antibody-based therapeutics #Artificial intelligence (AI) #Machine learning

Machine learning: Developing next generation antibody therapeutics

Ben Holland, CTO and Co-Founder of Antiverse, discusses how artificial intelligence and machine learning are benefitting antibody discovery and design. Modern experimental procedures, such as immunisation, B-cell screening, and synthetic library generation, have been pivotal in developing approximately 80 FDA-approved antibody therapeutics. This remarkable progress in antibody modalities for disease… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Lab automation #Machine learning

Technology: Artificial intelligence, machine learning and lab automation

In this free webinar, hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. You will hear from Jonathan Wingfield, Principal Scientist at AstraZeneca; Abraham Heifets, CEO at Atomwise; Raminderpal Singh, AI Expert at HitchhikersAI; alongside… Read More

Webinar date:
Sponsored by Benchling
#Webinars

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Library screening #Machine learning

AI: Advancing drug discovery with ultra-large library processing

Rob Scoffin, CEO, and Matthew Habgood, Principal Computational Chemistry Developer at Cresset, discuss the role of AI/ML in advancing screening methods by utilising virtual screening (VS) approaches to process compound libraries on an ultra-large scale. Drug discovery is a complex process that relies on designing and filtering potential drug candidates… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Clinical trial design #Collaboration #Exonate #Exploristics #Ophthalmology

Partners enhance trial design using cloud-based simulation

Exploristics and Exonate have announced the completion of a successful collaboration to optimise the study design for Exonate’s upcoming Phase IIb study for diabetic eye disease. The collaboration has supported ongoing development of Exonate’s lead candidate, EXN407, following a recent successful Phase Ib/IIa study in November. Read More

#News

MRI of the brain
#AI / data analytics / healthtech / informatics #epilepsy #Interview #Omics #Sitting Down With

Sitting down with… Stefanie Dedeurwaerdere, UCB

Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role, she is responsible for the development of UCB’s epilepsy discovery strategy, working with researchers to advance understanding of epilepsies while ensuring candidates for a future clinical treatment pipeline to… Read More

#Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Human disease models #Interview #Neurology #Neuroscience #Stem cells

Putting human data at the centre of drug discovery

Listen to this article on the DDW Podcast: James Peach is the Co-Founder and CEO of Human Centric Drug Discovery (HCDD), an Oxford University spin-out improving neurology drug discovery by bringing more human data to the process. Peach shared his insight with DDW’s Megan Thomas. MT: In what ways can human… Read More

#Exclusive Content #Opinion

Laboratory informatics
#AI / data analytics / healthtech / informatics #Data management #Neurodegenerative disorders #Screening

Informatics helps virtual biotech bring compound to clinical trial

This article is sponsored by Collaborative Drug Discovery. Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative diseases. The Libra portfolio includes three small molecule programmes, including their lead non-clinical programme targeting TRPML1 (based on… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Data security #Decentralised clinical trials

Decentralised identities: Blockchain based informed consent

Industry experts explain how blockchain can fundamentally enhance clinical trials. Obtaining consent from patients or healthy volunteers is a fundamental requirement for enrolling participants on to clinical trials. Methods for obtaining consent use paper-based Informed Consent Forms (ICFs) must be signed on site by the participant in the presence of… Read More

#Exclusive Content

Someone using a keyboard
#AI / data analytics / healthtech / informatics #Data management #Informatics #Market reporting

Drug discovery informatics market predicted to grow 12.6% by 2028

The drug discovery informatics market is predicted to grow from $3.77 billion in 2024 to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. The recent growth in the market is attributed to advancements in genomics and proteomics, the escalating complexity of… Read More

#Business & Investment #Market Reports #News #Trends & Analysis

Researcher loads DNA samples for PCR analysis
#AI / data analytics / healthtech / informatics #Oncology #Queen's University Belfast #RNAi #TechBio

Belfast techbio raises £1.4m to tackle complex diseases

Belfast-based techbio company AMPLY Discovery has raised over £1.4 ($1.7) million in grant funding to develop new drugs using its AI-driven drug discovery platform. The company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise a drug discovery platform developed by researchers in the… Read More

#Business & Investment #News